These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22150374)

  • 1. Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control.
    Mylotte D; Kavanagh GF; Peace AJ; Tedesco AF; Carmody D; O'Reilly M; Foley DP; Thompson CJ; Agha A; Smith D; Kenny D
    Platelets; 2012; 23(6):439-46. PubMed ID: 22150374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.
    Watala C; Golanski J; Pluta J; Boncler M; Rozalski M; Luzak B; Kropiwnicka A; Drzewoski J
    Thromb Res; 2004; 113(2):101-13. PubMed ID: 15115665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
    Watala C; Pluta J; Golanski J; Rozalski M; Czyz M; Trojanowski Z; Drzewoski J
    J Mol Med (Berl); 2005 Feb; 83(2):148-58. PubMed ID: 15723265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
    Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
    Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy.
    Singla A; Antonino MJ; Bliden KP; Tantry US; Gurbel PA
    Am Heart J; 2009 Nov; 158(5):784.e1-6. PubMed ID: 19853698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance.
    Renda G; Zurro M; Malatesta G; Ruggieri B; De Caterina R
    Haematologica; 2010 Dec; 95(12):2095-101. PubMed ID: 21123440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel.
    Mangiacapra F; Peace AJ; Wijns W; Barbato E
    J Thromb Thrombolysis; 2011 Jul; 32(1):54-8. PubMed ID: 21221715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients.
    Dichiara J; Bliden KP; Tantry US; Chaganti SK; Kreutz RP; Gesheff TB; Kreutz Y; Gurbel PA
    Platelets; 2007 Sep; 18(6):414-23. PubMed ID: 17763150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus.
    Lemkes BA; Bähler L; Kamphuisen PW; Stroobants AK; Van Den Dool EJ; Hoekstra JB; Nieuwland R; Gerdes VE; Holleman F
    J Thromb Haemost; 2012 Apr; 10(4):639-46. PubMed ID: 22252020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?
    Payne DA; Jones CI; Hayes PD; Webster SE; Ross Naylor A; Goodall AH
    Thromb Haemost; 2004 Jul; 92(1):89-96. PubMed ID: 15213849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus.
    Jackson CA; Greaves M; Boulton AJ; Ward JD; Preston FE
    Clin Sci (Lond); 1984 Nov; 67(5):551-5. PubMed ID: 6434224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
    Angiolillo DJ; Bernardo E; Ramírez C; Costa MA; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2006 Jul; 48(2):298-304. PubMed ID: 16843179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin non-responsiveness in Korean subjects on dual anti-platelet treatment determined by two different platelet function assays.
    Lee YW; Cho YH; Kim YH; Na JS; Shin HB; Ki CS; Choi TY; Lee YK
    Ann Clin Lab Sci; 2008; 38(2):126-31. PubMed ID: 18469357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
    Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
    J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.